Guaifenesin Tablet, Extended Release
Product Images NDC 11822-4260

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin (NDC 11822-4260). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rite Aid Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (1200 mg Blister Carton (14 (1 x 14) Tablets))

Package Label-principal Display Panel (1200 mg Blister Carton (14 (1 x 14) Tablets))
Packaging label for Maximum Strength Mucus Relief Guaifenesin Extended-Release Tablets 1200 mg by Rite Aid Corporation. The label indicates 14 extended-release tablets, designed for 12-hour relief as an expectorant. The label features blue and white colors with red accents and includes drug facts, inactive ingredients, usage directions, and contact information. The product is made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.